ABSTRACT

Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19   [open pdf - 0B]

From the Background: "Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether hydroxychloroquine can prevent symptomatic infection after SARS-CoV-2 exposure is unknown."

Author:
Publisher:
Date:
2020-06-03
Series:
Copyright:
2020 Massachusetts Medical Society
Retrieved From:
New England Journal of Medicine: https://www.nejm.org/
Media Type:
application/pdf
URL:
Help with citations